Trial patients OD after clinic failed to weigh them
A FDA warning letter has been sent to a clinical investigator who administered incorrect doses of investigational drugs having taken the patient’s weight and height from their driving license.
A FDA warning letter has been sent to a clinical investigator who administered incorrect doses of investigational drugs having taken the patient’s weight and height from their driving license.
Despite criticism in certain quarters, joint GMP inspections represent the best use of resources in an increasingly globalised market, according to the EMEA.
Switzerland-based CRO PFC Pharma Focus is entering the South American market through a partnership with Argentinean company Blanchard y Asociados.